Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;58(1):590-2.
doi: 10.1128/AAC.01752-13. Epub 2013 Oct 21.

Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany

Affiliations

Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany

Sönke Andres et al. Antimicrob Agents Chemother. 2014.

Abstract

Four out of 143 phenotypically isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis strains that were isolated from patients in Germany in 2011 had mutations in the rifampin resistance-determining region of rpoB. After performing drug susceptibility testing (DST) with two methods, the proportion method on Löwenstein-Jensen medium and using the Bactec 960 Mycobacteria Growth Indicator Tube system, we conclude that the two methods are equally reliable for phenotypic DST and MIC determination.

PubMed Disclaimer

Figures

FIG 1
FIG 1
RMP MICs below the critical concentrations determined by the Bactec 960 MGIT system and the proportion method on LJ medium. Only the concentrations tested, beginning with 2.5 μg/ml, are given on the y axes. The adjusted critical concentrations for the two methods (LJ medium, 40 μg/ml; Bactec 960 MGIT, 1 μg/ml) are represented by a dashed line.

References

    1. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1320–1330 - PubMed
    1. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A. 2009. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501–3506. 10.1128/JCM.01209-09 - DOI - PMC - PubMed
    1. Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D. 2012. Diagnosis of tuberculosis and drug resistance: what can new tools bring us? Int. J. Tuberc. Lung Dis. 16:860–870. 10.5588/ijtld.12.0180 - DOI - PubMed
    1. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635–2640. 10.1128/JCM.00521-07 - DOI - PMC - PubMed
    1. Hillemann D, Richter E, Rüsch-Gerdes S. 2006. Use of the BACTEC Mycobacteria Growth Indicator Tube 960 automated system for recovery of mycobacteria from 9,558 extrapulmonary specimens, including urine samples. J. Clin. Microbiol. 44:4014–4017. 10.1128/JCM.00829-06 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources